PeptidePedia The community reference

Crude peptide (revision 5)

Old revision·16:31, 12 Oct 2024·CrudePeptidePearl

This is an old revision of this page, as it stood at 16:31, 12 Oct 2024, saved by CrudePeptidePearl with the summary attribute the stability figure to the study and its duration. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Crude peptide
Obtained fromCleavage of the assembled chain
Typical purityHighly variable; sequence-dependent
Principal impuritiesDeletion and truncated sequences
Topic infobox · conventions

Crude peptide is the material obtained immediately after cleavage from the solid support, before any chromatographic purification. It contains the target peptide together with every by-product that accumulated during assembly and cleavage.[1]

Its purity is highly variable and is largely determined by sequence. An easy 10-residue sequence may cleave at high purity; a difficult 40-residue sequence may cleave at well under half. That figure sets the cost and difficulty of everything that follows.[1]

Crude peptide is sold as such in some markets, principally where the purchaser intends to purify it. Material described only as "crude" is not a defective product; it is an intermediate, and describing it accurately is what distinguishes it from a purified one.[2]

What is in it

[edit]

The dominant impurities are sequence-related: deletion sequences missing one or more residues where a coupling failed, truncated sequences where a chain was capped, and any peptide bearing residual protecting groups where cleavage was incomplete.[1][3]

Cleavage adds its own. Strongly acidic conditions release reactive cations from the protecting groups, which can alkylate tryptophan, methionine and cysteine unless scavengers capture them; oxidation and, for susceptible sequences, aspartimide formation also occur.

References

  1. ^ a b c Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." Journal of Peptide Science 22(1):4–27 (2016). PMID 26785684.
  2. ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
  3. ^ Merrifield RB. "Solid phase peptide synthesis. I. The synthesis of a tetrapeptide." Journal of the American Chemical Society 85(14):2149–2154 (1963). DOI:10.1021/ja00897a025.